Call Me™ Registration: Click Here (Available 15 minutes prior to call) After the live webcast, the event will be archived on PDS Biotech’s website for six months. About PDS Biotechnology ...

PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming ...

PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.25.

BLUE BELL, Pa., April 15, 2024 (GLOBE NEWSWIRE) -- PDS®, a leading provider of human capital management (HCM) solutions, is thrilled to announce that April 15th, 2024, marks our 50th anniversary ...

PDS Biotechnology Corporation (NASDAQ:PDSB) Q2 2023 Earnings Conference Call August 14, 2023 8:00 AM ETCompany ParticipantsFrank Bedu-Addo - Chief Executive ...

--PDS Biotechnology Corporation, a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the Company will host a conference ...

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.29.

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Conference Call March 27, 2024 8:00 AM ETCompany Participants. Dr. Frank Bedu-Addo - Chief Executive Officer Lars Boesgaard - Chief ...